In the Archaea Haloferax volcanii, membrane protein biogenesis and protein synthesis rates are affected by decreased ribosomal binding to the translocon.
In the haloarchaea Haloferax volcanii, ribosomes are found in the cytoplasm and membrane-bound at similar levels. Transformation of H. volcanii to express chimeras of the translocon components SecY and SecE fused to a cellulose-binding domain substantially decreased ribosomal membrane binding, relative to non-transformed cells, likely due to steric hindrance by the cellulose-binding domain. Treatment of cells with the polypeptide synthesis terminator puromycin, with or without low salt washes previously shown to prevent in vitro ribosomal membrane binding in halophilic archaea, did not lead to release of translocon-bound ribosomes, indicating that ribosome release is not directly related to the translation status of a given ribosome. Release was, however, achieved during cell starvation or stationary growth, pointing at a regulated manner of ribosomal release in H. volcanii. Decreased ribosomal binding selectively affected membrane protein levels, suggesting that membrane insertion occurs co-translationally in Archaea. In the presence of chimera-incorporating sterically hindered translocons, the reduced ability of ribosomes to bind in the transformed cells modulated protein synthesis rates over time, suggesting that these cells manage to compensate for the reduction in ribosome binding. Possible strategies for this compensation, such as a shift to a post-translational mode of membrane protein insertion or maintained ribosomal membrane-binding, are discussed.
Department of Life Sciences, Ben Gurion University, Beersheva 84105, Israel.
Gabriela
G
Ring
Jerry
J
Eichler
D001105:Archaea / Q000378:metabolism; D019843:Archaeal Proteins / Q000737:chemistry / Q000502:physiology*; D002462:Cell Membrane / Q000378:metabolism; D002482:Cellulose / Q000737:chemistry; D003593:Cytoplasm / Q000378:metabolism; D003720:Densitometry; D004591:Electrophoresis, Polyacrylamide Gel; D004721:Endoplasmic Reticulum / Q000378:metabolism; D019622:Haloferax volcanii / Q000378:metabolism*; D007700:Kinetics; D008565:Membrane Proteins / Q000378:metabolism; D011485:Protein Binding; D014176:Protein Biosynthesis; D017434:Protein Structure, Tertiary; D021381:Protein Transport; D011506:Proteins / Q000378:metabolism*; D011691:Puromycin / Q000494:pharmacology; D012313:RNA / Q000378:metabolism; D012335:RNA, Ribosomal / Q000737:chemistry; D012270:Ribosomes / Q000737:chemistry / Q000378:metabolism*; D012492:Salts / Q000494:pharmacology; D013347:Subcellular Fractions; D013997:Time Factors
D019843:Archaeal Proteins; D008565:Membrane Proteins; D011506:Proteins; D012335:RNA, Ribosomal; D012492:Salts; D011691:Puromycin; D012313:RNA; D002482:Cellulose